We have detected four different mutations in the porphobilinogen deaminase (PBGD) gene in acute intermittent porphyria (AIP) families from England, Norway, and Sweden. A splicing mutation in the first position of intron 8 (Int8 +1) was found in a family from England and a missense mutation in exon 12 (Glu250) was detected in a Norwegian family. Two mutations were identified in Swedish families, one splicing mutation in the first position of intron 3 (Int3 + 1) and one missense mutation in exon 8 (Pro119). (J Med Genet 1995;32:979-981) 
Abstract
We have detected four different mutations in the porphobilinogen deaminase (PBGD) gene in acute intermittent porphyria (AIP) families from England, Norway, and Sweden. A splicing mutation in the first position of intron 8 (Int8 +1) was found in a family from England and a missense mutation in exon 12 (Glu250) was detected in a Norwegian family. Two mutations were identified in Swedish families, one splicing mutation in the first position of intron 3 (Int3 + 1) and one missense mutation in exon 8 (Pro119). PBGD is the third enzyme involved in haem synthesis, and AIP patients have a partial deficiency of the enzyme activity. When the demand for haem is increased, for example by alcohol or drug usage, the precursors ALA (6-aminolaevulinic acid) and PBG (porphobilinogen) accumulate in tissues and are probably responsible for the toxic effects in the neuropsychiatric porphyrias. AIP seldom presents before puberty, many carriers are asymptomatic, and the disease can often be difficult to diagnose. The symptoms are varied with sometimes severe attacks of abdominal pain, paralysis, mental disturbances, and autonomic dysfunction." IA) .
The mutation in exon 8 (Pro"9) created a cleavage site for the restriction enzyme XmnI. After PCR amplification of a 765 bp fragment, the mutated allele was cleaved into two fragments of 412 and 353 bp. These fragments were separated on a 1 % agarose gel (fig 1 B) (fig 2A) . This mutation alters ion step of a cleavage site for the restriction enzyme XmnI and can thus easily be detected (fig 1 B) . It was as template found in six AIP patients and one possible [plification. carrier, diagnosed by conventional clinical and were ident-biochemical methods. Six members of the famimers were ily, in whom the diagnosis of AIP had been pmol, with rejected, did not carry the mutation. In ad-1/l. dition, DNA from 21 normal Swedish controls rated from were screened for this mutation and were ,acrylamide shown to be negative. ns, and the Sequenase SPLICING MUTATIONS Two splicing mutations were detected, one at the exon 3/intron 3 border and the other at the tY exon 8/intron 8 border. The mutation found td +)craend in the first position of intron 8 (Int8 + 1), a G to T substitution, was found in a large English family ( fig 2B) . One of the members of this family had an uncertain AIP diagnosis, and carrier status could now be established.
The other splicing mutation, a G to A substitution in the first position of intron 3 (Int3 + 1), was found in a Swedish family with five AIP patients, one inconclusive, and four unaffected family members ( fig 2C) . This mutation can be detected by cleavage with the restriction enzyme BstNI ( fig 1A) .
GLU250
In a large Norwegian family with six AIP patients and 22 unaffected family members, a mutation was found in exon 12. This G to C substitution in position 748 converts Glu250 to Ala ( fig 2D) . A 
